PROM1 and central nervous system cancer: These spheroids expressed the prototypic stemness gene CD133 whereas parental GLUC2 spheroids did not (Figure 3J), suggesting that glioma cells dynamically respond to genotoxic therapy by acquiring stem-like morphology and characteristics (47).